Live from the NIH registry
Studies recruiting near Escondido right now
Top 25 of 1,307 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
University of California San Diego Moores Cancer Center (Adults only) — La Jolla, California (23.1 mi)
· Sponsor: Pierre Fabre Medicament
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
UCSD Moores Cancer Center — La Jolla, California (23.1 mi)
· Sponsor: GT Medical Technologies, Inc.
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
San Diego Neurosurgery — Encinitas, California (14.4 mi)
· Sponsor: Collagen Matrix
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Gram-negative Bacterial Infections
Phase 2
Interventional 48 participants sought
Rady Children's Hospital — San Diego, California (29.4 mi)
· Sponsor: Pfizer
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rady Children's Hospital - San Diego — San Diego, California (29.4 mi)
· Sponsor: National Cancer Institute (NCI)
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
Post-Traumatic Stress Disorder (PTSD)
Phase 2
Interventional 240 participants sought
VA San Diego Healthcare System, San Diego, CA — San Diego, California (29.4 mi)
· Sponsor: VA Office of Research and Development
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
University of California San Diego — San Diego, California (29.4 mi)
· Sponsor: Acepodia Biotech, Inc.
BladdEr Full OR Empty for Pelvic Radiation Therapy
Pelvic Neoplasm
Phase 3
Interventional 300 participants sought
University of California, San Diego — San Diego, California (29.4 mi)
· Sponsor: University of California, San Diego
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — San Diego, California (29.4 mi)
· Sponsor: Sameek Roychowdhury
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Artemis Institute for Clinical Research — San Diego, California (29.4 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Headlands Research California, LLC — Escondido, California (1.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — La Jolla, California (23.1 mi)
· Sponsor: Salma Health, Inc.
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Profound Research — Oceanside, California (18.3 mi)
· Sponsor: Alveus Therapeutics, Inc.
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
UCSD Altman Clinical and Translational Research Institute Building — La Jolla, California (23.1 mi)
· Sponsor: Amgen
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
University of California, San Diego — La Jolla, California (23.1 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Urinary Tract Infection, Recurrent
Phase 1, Phase 2
Interventional 32 participants sought
University of California, San Diego — La Jolla, California (23.1 mi)
· Sponsor: University of California, San Diego
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
Eating Disorders, Sexual Minorities
Phase 1
Interventional 30 participants sought
San Diego State University — San Diego, California (29.4 mi)
· Sponsor: Auburn University
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Kaiser Permanente - San Marcos — San Marcos, California (5.5 mi)
· Sponsor: Hoffmann-La Roche
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of California San Diego — San Diego, California (29.4 mi)
· Sponsor: Jaeb Center for Health Research
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — La Jolla, California (23.1 mi)
· Sponsor: AstraZeneca
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Acclaim Clinical Research- Site Number : 8400068 — San Diego, California (29.4 mi)
· Sponsor: Sanofi
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Clinical Applications Laboratories, Inc — San Diego, California (29.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)
Knee Osteoarthritis
Phase 3
Interventional 300 participants sought
Horizon Clinical Research — La Mesa, California (25.5 mi)
· Sponsor: Doron Therapeutics Inc.
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Prostate Cancer
Phase 4
Interventional 142 participants sought
University of California San Diego Health — San Diego, California (29.4 mi)
· Sponsor: Blue Earth Diagnostics
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
Brain Metastases, Adult, Neurocognitive Function
Phase 2
Interventional 90 participants sought
Moores Cancer Center — San Diego, California (29.4 mi)
· Sponsor: Jona Hattangadi-Gluth